A study exploring the role of EZH2 mutation in MPN pathogenesis inadvertently identified up-regulation of S100A8 and S100A9 in EZH2-deleted, JAK2-mutated MPN-model cells [19]. Here, JAK2 is linked to myeloproliferative disorder.